Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisition

Reuters12-12

Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisition

Overview

Biotechnology firm's fiscal Q1 revenue rose yr/yr
Net loss increased due to Cyclo acquisition expenses
R&D expenses rose significantly after Cyclo acquisition

Outlook

Company did not provide specific financial guidance for the current quarter or fiscal year in press release

Result Drivers

INCREASED R&D EXPENSES - R&D expenses rose to $7.5 mln from $1.3 mln due to Cyclo acquisition
ACQUISITION IMPACT - Net loss increased due to Cyclo Therapeutic's expenses post-acquisition

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q1 Revenue		$240,000
Q1 Net Income		-$9.80 mln
Q1 Operating Income		-$10.14 mln

Press Release: ID:nGNX53ryVN

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590549270?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 05:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590549270","market":"us","top_or_hot":-1,"title":"Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisition","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisition</title></head><body><p><span>Overview</span></p><ul><li><p>Biotechnology firm's fiscal Q1 revenue rose yr/yr</p></li><li><p>Net loss increased due to Cyclo acquisition expenses</p></li><li><p>R&amp;D expenses rose significantly after Cyclo acquisition</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company did not provide specific financial guidance for the current quarter or fiscal year in press release</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>INCREASED R&amp;D EXPENSES - R&amp;D expenses rose to $7.5 mln from $1.3 mln due to Cyclo acquisition</p></li><li><p>ACQUISITION IMPACT - Net loss increased due to Cyclo Therapeutic's expenses post-acquisition</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q1 Revenue</p></td><td></td><td><p>$240,000</p></td><td></td></tr><tr><td><p>Q1 Net Income</p></td><td></td><td><p>-$9.80 mln</p></td><td></td></tr><tr><td><p>Q1 Operating Income</p></td><td></td><td><p>-$10.14 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nGNX53ryVN</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisition\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-12 05:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisition</title></head><body><p><span>Overview</span></p><ul><li><p>Biotechnology firm's fiscal Q1 revenue rose yr/yr</p></li><li><p>Net loss increased due to Cyclo acquisition expenses</p></li><li><p>R&amp;D expenses rose significantly after Cyclo acquisition</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company did not provide specific financial guidance for the current quarter or fiscal year in press release</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>INCREASED R&amp;D EXPENSES - R&amp;D expenses rose to $7.5 mln from $1.3 mln due to Cyclo acquisition</p></li><li><p>ACQUISITION IMPACT - Net loss increased due to Cyclo Therapeutic's expenses post-acquisition</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q1 Revenue</p></td><td></td><td><p>$240,000</p></td><td></td></tr><tr><td><p>Q1 Net Income</p></td><td></td><td><p>-$9.80 mln</p></td><td></td></tr><tr><td><p>Q1 Operating Income</p></td><td></td><td><p>-$10.14 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nGNX53ryVN</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4205","symbol_name":"房地产经营公司","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nL1N3XH10Z:1","article_id":"2590549270","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590549270","pubTimestamp":1765487560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisitionOverviewBiotechnology firm's fiscal Q1 revenue rose yr/yrNet loss increased due to Cyclo acquisition expensesR&D expenses ro","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4205":"房地产经营公司","BK4233":"房地产运营公司","RFL":"Rafael Holdings, Inc.","BK4007":"制药"},"translate_title":"收购Cyclo后费用增加，Rafael Holdings第一季度净亏损扩大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RFL":0.9},"content_text":"Rafael Holdings' Q1 net loss widens as expenses rise after Cyclo acquisitionOverviewBiotechnology firm's fiscal Q1 revenue rose yr/yrNet loss increased due to Cyclo acquisition expensesR&D expenses rose significantly after Cyclo acquisitionOutlookCompany did not provide specific financial guidance for the current quarter or fiscal year in press releaseResult DriversINCREASED R&D EXPENSES - R&D expenses rose to $7.5 mln from $1.3 mln due to Cyclo acquisitionACQUISITION IMPACT - Net loss increased due to Cyclo Therapeutic's expenses post-acquisitionKey DetailsMetricBeat/MissActualConsensus EstimateQ1 Revenue$240,000Q1 Net Income-$9.80 mlnQ1 Operating Income-$10.14 mlnPress Release: ID:nGNX53ryVNFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,merge","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590549270","isCrawlerRequest":true}